Thermo Fisher Scientific EPS (Basic) increased by 22.0% to $5.22 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $4.80 to $5.22. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows relatively stable performance with a -2.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
is_eps_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.65 | $4.83 | $4.21 | $5.66 | $4.25 | $3.82 | $4.02 | $3.34 | $3.53 | $4.44 | $4.21 | $3.47 | $4.05 | $4.26 | $4.80 | $3.99 | $4.28 | $4.28 | $5.22 |
| QoQ Change | — | +3.9% | -12.8% | +34.4% | -24.9% | -10.1% | +5.2% | -16.9% | +5.7% | +25.8% | -5.2% | -17.6% | +16.7% | +5.2% | +12.7% | -16.9% | +7.3% | +0.0% | +22.0% |
| YoY Change | — | — | — | — | -8.6% | -20.9% | -4.5% | -41.0% | -16.9% | +16.2% | +4.7% | +3.9% | +14.7% | -4.1% | +14.0% | +15.0% | +5.7% | +0.5% | +8.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.